The neurotransmitter glutamate is essential for regulating everything from mood to memory, but it can also encourage a toxic buildup of protein, which can contribute to Alzheimer's and related ...

For the early detection of Alzheimer's disease, so-called p-tau proteins in the blood are not as disease-specific as ...

Older women who take menopausal hormone therapy may be at a higher risk of Alzheimer's. A study published in Science Advances ...

A UTA, University of California–San Francisco study explores why some nerve cells are more vulnerable to neurodegeneration ...

Elevated levels of p-tau 181 and 217 in cerebrospinal fluid are considered to reflect early Alzheimer's disease pathology.

A new study suggests that women who use a popular hormonal menopause treatment later in life may be at a higher risk of developing Alzheimer’s disease.

The results of a new study show that suppressing KCTD20, which responds to the neurotransmitter glutamate, activates a mechanism for expelling tau proteins.

Older women who underwent hormone replacement therapy during and after menopause had high markers associated with Alzheimer's ...

USC Stem Cell scientists discover a new way to rid cells of toxic tau protein in a study involving mice and lab-grown human ...

Researchers at Northwestern University have made a breakthrough in identifying a way for Alzheimer's disease to be treated ...

"Studies have shown that vulnerability to Alzheimer's-related changes in the brain increase in women from pre- to ...

Researchers identified a gene that seems to help slow brain aging in women, and studied links between hormone therapy, ...